Tectonic Therapeutic, Inc. Files 8-K

Ticker: TECX · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1681087

Tectonic Therapeutic, Inc. 8-K Filing Summary
FieldDetail
CompanyTectonic Therapeutic, Inc. (TECX)
Form Type8-K
Filed DateJan 13, 2025
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: company-information, legal

TL;DR

Tectonic Therapeutic (formerly AVROBIO) updated its address and official info in an 8-K filing.

AI Summary

On January 13, 2025, Tectonic Therapeutic, Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 490 Arsenal Way, Suite 210, Watertown, MA 02472. The company was formerly known as AVROBIO, Inc. and AvroBio, Inc., with name changes occurring on January 31, 2018, and July 29, 2016, respectively.

Why It Matters

This filing provides an update on the company's official reporting information, including its current name and address, which is important for investors and regulatory tracking.

Risk Assessment

Risk Level: low — This filing is primarily administrative, confirming the company's name and address, and does not contain material financial or operational news.

Key Players & Entities

  • Tectonic Therapeutic, Inc. (company) — Registrant
  • AVROBIO, Inc. (company) — Former Company Name
  • AvroBio, Inc. (company) — Former Company Name
  • January 13, 2025 (date) — Date of Report
  • 490 Arsenal Way, Suite 210, Watertown, MA 02472 (location) — Principal Executive Offices

FAQ

What is the exact name of the registrant as specified in its charter?

The exact name of the registrant is Tectonic Therapeutic, Inc.

When was the earliest event reported in this 8-K filing?

The earliest event reported is January 13, 2025.

What is the company's principal executive office address?

The company's principal executive offices are located at 490 Arsenal Way, Suite 210, Watertown, Massachusetts 02472.

What were the former names of Tectonic Therapeutic, Inc.?

The company was formerly known as AVROBIO, Inc. and AvroBio, Inc.

On what dates did the company change its name from its former identities?

The name change from AVROBIO, Inc. occurred on January 31, 2018, and the name change from AvroBio, Inc. occurred on July 29, 2016.

Filing Stats: 542 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2025-01-13 16:03:39

Key Financial Figures

  • $0.0001 — nge on which registered Common Stock, $0.0001 par value per share TECX The Nasdaq

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Corporate Presentation dated January 2025. 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TECTONIC THERAPEUTIC, INC. By: /s/ Daniel Lochner Daniel Lochner Chief Financial Officer Dated: January 13, 2025

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.